Skip to content
Biotech Policy track

Biotech Policy

The US regulatory framework, the FDA, gene therapy and CRISPR rules, agricultural biotech, biosecurity, public health law, genetic privacy, and future governance.

8Modules
FreeAlways
Self-pacedNo login
BP1
Regulatory Landscape
A single CRISPR-edited mushroom can require approval from three different federal agencies.
BP2
FDA
In 1937, a Tennessee pharmaceutical company released a new liquid formulation of an antibiotic called sulfanilamide.
BP3
Gene Therapy
In December 2023, the FDA approved a drug called CASGEVY.
BP4
Ag Biotech
In 2016, a Pennsylvania State University plant pathologist named Yinong Yang submitted documents to the USDA describing a new mushroom variety.
BP5
Biosecurity
In 2005, researchers at the US Centers for Disease Control and Prevention published a paper in Science describing how they had reconstructed the 1918 influenza virus.
BP6
Public Health Law
In February 1905, the US Supreme Court decided a case called *Jacobson v.
BP7
Privacy & Genetics
In April 2018, police in California arrested a 72-year-old man named Joseph James DeAngelo.
BP8
Future Governance
In 2023, a research group based at Boston University and several other institutions published a paper describing a new SARS-CoV-2 variant they had constructed in the lab — combining the spike protein of Omicron with the genetic backbone of the original Wuhan strain.
Other tracks
FoundationsGenomicsMarine BiologyBiotech